Correlation Between Incyte and Jazz Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Incyte and Jazz Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Incyte and Jazz Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Incyte and Jazz Pharmaceuticals PLC, you can compare the effects of market volatilities on Incyte and Jazz Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Incyte with a short position of Jazz Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Incyte and Jazz Pharmaceuticals.
Diversification Opportunities for Incyte and Jazz Pharmaceuticals
0.22 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Incyte and Jazz is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Incyte and Jazz Pharmaceuticals PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Jazz Pharmaceuticals PLC and Incyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Incyte are associated (or correlated) with Jazz Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Jazz Pharmaceuticals PLC has no effect on the direction of Incyte i.e., Incyte and Jazz Pharmaceuticals go up and down completely randomly.
Pair Corralation between Incyte and Jazz Pharmaceuticals
Given the investment horizon of 90 days Incyte is expected to under-perform the Jazz Pharmaceuticals. In addition to that, Incyte is 1.4 times more volatile than Jazz Pharmaceuticals PLC. It trades about -0.08 of its total potential returns per unit of risk. Jazz Pharmaceuticals PLC is currently generating about -0.03 per unit of volatility. If you would invest 12,361 in Jazz Pharmaceuticals PLC on November 8, 2024 and sell it today you would lose (354.00) from holding Jazz Pharmaceuticals PLC or give up 2.86% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Incyte vs. Jazz Pharmaceuticals PLC
Performance |
| Timeline |
| Incyte |
| Jazz Pharmaceuticals PLC |
Incyte and Jazz Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Incyte and Jazz Pharmaceuticals
The main advantage of trading using opposite Incyte and Jazz Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Incyte position performs unexpectedly, Jazz Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Jazz Pharmaceuticals will offset losses from the drop in Jazz Pharmaceuticals' long position.| Incyte vs. Alnylam Pharmaceuticals | Incyte vs. United Therapeutics | Incyte vs. Ultragenyx | Incyte vs. Apellis Pharmaceuticals |
| Jazz Pharmaceuticals vs. Incyte | Jazz Pharmaceuticals vs. Alnylam Pharmaceuticals | Jazz Pharmaceuticals vs. United Therapeutics | Jazz Pharmaceuticals vs. Ultragenyx |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |